<DOC>
	<DOCNO>NCT00928694</DOCNO>
	<brief_summary>This study determine definitive bioequivalence United States ( U.S. ) United Kingdom ( UK ) formulation fenofibrate follow administration single dose healthy adult subject .</brief_summary>
	<brief_title>Fenofibrate Bioequivalence Study ( 0767-031 )</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>Subject good health Subject willing follow study guideline Subject uncontrolled high blood pressure , impair glucose tolerance , diabetes , major disease chronic condition would confound result study make participation unsafe Female subject receive oral contraceptive hormone replacement therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>